How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

12,784 results for

"covid 19" OR "novel coronavirus"

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Infection prevention and control for novel coronavirus (COVID-19): interim guidance for acute healthcare settings

Infection prevention and control for novel coronavirus (COVID-19): interim guidance for acute healthcare settings Infection prevention and control for coronavirus disease (COVID-19): Interim guidance for acute healthcare settings - Canada.ca Language selection Search Search Canada.ca Search Menu Main Menu You are here: Infection prevention and control for coronavirus disease (COVID-19): Interim guidance for acute healthcare settings Table of Contents Introduction The Public Health Agency (...) of Canada (the Agency) develops infection prevention and control (IPC) guidelines to provide evidence-based recommendations to complement provincial/territorial public health efforts in monitoring, preventing, and controlling healthcare-associated infections. This is the preliminary edition of IPC guidance on the coronavirus disease (COVID-19) that was first identified in Wuhan, China. The intended use of this document, infection prevention and control for coronavirus disease (COVID-19): interim

2020 CPG Infobase

2. Novel coronavirus (COVID-19) guidance for acute care

Novel coronavirus (COVID-19) guidance for acute care 1 | Pa g e Ministry of Health Novel Coronavirus (COVID-19) Guidance for Acute Care Version 2 – February 1 1, 2020 This guidance document provides basic information only. It is not intended to take the place of medical advice, communicable diseases surveillance protocols, diagnosis or treatment. What you need to know Acute care settings should: 1. Undertake active screening (asking questions) and passive screening (signage) of patients (...) to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV), Severe Acute Respiratory Syndrome (SARS-CoV), and COVID-19. A novel coronavirus is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Detailed investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV from dromedary camels to humans, likely through bat reservoirs. Several known coronaviruses

2020 CPG Infobase

3. Interim guidance: public health management of cases and contacts associated with novel coronavirus (COVID-19) in the community

Interim guidance: public health management of cases and contacts associated with novel coronavirus (COVID-19) in the community Interim Guidance: Public Health Management of cases and contacts associated with novel coronavirus (COVID-19) in the community March 10, 2020 CONTEXT The British Columbia Centre for Disease Control (BCCDC) has adapted the interim guidance from the Public Health Agency of Canada (PHAC) for Regional Health Authorities (RHA) for public health management of human illness (...) caused by the novel coronavirus (COVID-19). The strategy outlined in this guidance is aligned with a containment goal (i.e. to reduce opportunities for transmission to contacts in the community) and is based on the assumption that the virus is primarily spread while the case is symptomatic. This guidance is based on current available scientific evidence and expert opinion and is subject to change as new information on the clinical spectrum, transmissibility and epidemiology becomes available

2020 CPG Infobase

4. Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care

Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care Health Protection Scotland This document is uncontrolled when printed. Before use check the HPS COVID-19 page to verify this is the current version Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care Version 10.4 Publication date 27 March 2020 Health Protection Scotland 1 Version History Version Date Summary of changes V1.0 23/01/20 First (...) equipment 12 11.5. Carpeted flooring and soft furnishings 12 11.6. On leaving the room 13 11.7. Cleaning of communal areas 13 11.8. Attending deaths 13 12. Further information 13 Appendix 1: Contact details for local Health Protection Teams 14 Health Protection Scotland 4 Appendix 2: Putting on and removing Personal Protective Equipment (PPE) 15 Instructional video 16 Health Protection Scotland 5 1. Introduction Novel coronavirus (COVID-19) is a new is a new strain of coronavirus first identified

2020 Covid-19 Ad hoc guidelines

5. A systematic review of convalescent plasma treatment for SAR coronavirus and MERS coronavirus: a possible reference for a 2019 novel coronavirus (COVID-19) treatment option

A systematic review of convalescent plasma treatment for SAR coronavirus and MERS coronavirus: a possible reference for a 2019 novel coronavirus (COVID-19) treatment option Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2020 PROSPERO

6. Chloroquine phosphate for novel coronavirus (COVID-19) pneumonia : a systematic review and meta-analysis of randomised controlled trials

Chloroquine phosphate for novel coronavirus (COVID-19) pneumonia : a systematic review and meta-analysis of randomised controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2020 PROSPERO

7. Clinical effect of integrated traditional Chinese medicine and western medicine of 2019 novel coronavirus pneumonia (COVID-19): a network meta-analysis

Clinical effect of integrated traditional Chinese medicine and western medicine of 2019 novel coronavirus pneumonia (COVID-19): a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2020 PROSPERO

8. Novel Coronavirus 2019 (COVID-19)

Novel Coronavirus 2019 (COVID-19) Novel Coronavirus 2019 (COVID-19) | ACOG Clinical Guidance Journals & Publications Patient Education Topics Featured Clinical Topics Hi, Featured Clinical Topics Clinical Guidance Novel Coronavirus 2019 (COVID-19) Practice Advisory March 2020 Jump to Resources Share By reading this page you agree to ACOG's Terms and Conditions. . The Centers for Disease Control and Prevention (CDC) has released and guidance for . Travel Due to the current risk of COVID-19, CDC (...) women. For more information on seasonal influenza and recommendations for pregnant women see the and . The American College of Obstetricians and Gynecologists will continue to closely monitor the evolution of the 2019 novel coronavirus (COVID-19) in collaboration with the CDC. New and updated information will be shared as it becomes available. This Practice Advisory was developed by the American College of Obstetricians and Gynecologists’ Immunization, Infectious Disease, and Public Health

2020 American College of Obstetricians and Gynecologists

9. Prevalence of symptoms and comorbid conditions in novel coronavirus (COVID-19)-infected adult and paediatric patients: a systematic review and meta-analysis of first three-month data of the outbreak

Prevalence of symptoms and comorbid conditions in novel coronavirus (COVID-19)-infected adult and paediatric patients: a systematic review and meta-analysis of first three-month data of the outbreak Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2020 PROSPERO

10. Prevalence and characteristics of fever in novel coronavirus (COVID-19)-infected adult and paediatric patients:a systematic review and meta-analysis of first three-month data of the outbreak

Prevalence and characteristics of fever in novel coronavirus (COVID-19)-infected adult and paediatric patients:a systematic review and meta-analysis of first three-month data of the outbreak Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2020 PROSPERO

11. Efficacy of integrative Traditional Chinese and Western medicine for the treatment of patients infected with 2019 novel coronavirus (COVID-19): a systematic review and meta-analysis

Efficacy of integrative Traditional Chinese and Western medicine for the treatment of patients infected with 2019 novel coronavirus (COVID-19): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2020 PROSPERO

12. The risk factors of acquiring severe 2019 novel coronavirus (COVID-19): a meta-analysis

The risk factors of acquiring severe 2019 novel coronavirus (COVID-19): a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2020 PROSPERO

13. The risk factors for death from 2019 novel coronavirus (COVID-19)-infected pneumonia

The risk factors for death from 2019 novel coronavirus (COVID-19)-infected pneumonia Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2020 PROSPERO

14. Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19)

Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19) Abbreviations: ABG, arterial blood gases; CDC, Centers for Disease Control and Prevention; HIV, human immunodeficiency virus. Healthcare providers should immediately notify their local or state health department in the event of a PUI for COVID-19 and should contact and consult with their local and/or state health department for recommendations on testing PUIs for COVID-19. Outpatient (...) Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19) Unlike influenza and other respiratory illnesses, based on a limited number of confirmed COVID-19 cases, pregnant women do not appear to be at increased risk for severe disease. However, given the lack of data and experience with other coronaviruses such as SARS-CoV and MERS-CoV, diligence in evaluating and treating pregnant women is warranted. This algorithm is designed to aid practitioners in promptly

2020 American College of Obstetricians and Gynecologists

15. Reconstruction of Transmission Pairs for novel Coronavirus Disease 2019 (COVID-19) in mainland China: Estimation of Super-spreading Events, Serial Interval, and Hazard of Infection. Full Text available with Trip Pro

Reconstruction of Transmission Pairs for novel Coronavirus Disease 2019 (COVID-19) in mainland China: Estimation of Super-spreading Events, Serial Interval, and Hazard of Infection. Knowledge on the epidemiological features and transmission patterns of COVID-19 is accumulating. Detailed line-list data with household settings can advance the understanding of COVID-19 transmission dynamics.A unique database with detailed demographic characteristics, travel history, social relationships (...) , and epidemiological timelines for 1,407 transmission pairs that formed 643 transmission clusters in mainland China was reconstructed from 9,120 COVID-19 confirmed cases reported during January 15 - February 29, 2020. Statistical model fittings were used to identify the super-spreaders and estimate serial interval distributions. Age and gender-stratified hazard of infection were estimated for household versus non-household transmissions.There were 34 primary cases identified as super-spreaders, with 5 super

2020 Clinical Infectious Diseases

16. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Full Text available with Trip Pro

Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). The emergence of coronavirus disease 2019 (COVID-19) is a major healthcare threat. The current method of detection involves a quantitative polymerase chain reaction (qPCR)-based technique, which identifies the viral nucleic acids when present in sufficient quantity. False-negative results can be achieved and failure to quarantine the infected patient would be a major setback in containing the viral transmission (...) . We aim to describe the time kinetics of various antibodies produced against the 2019 novel coronavirus (SARS-CoV-2) and evaluate the potential of antibody testing to diagnose COVID-19.The host humoral response against SARS-CoV-2, including IgA, IgM, and IgG response, was examined by using an ELISA-based assay on the recombinant viral nucleocapsid protein. 208 plasma samples were collected from 82 confirmed and 58 probable cases (qPCR negative but with typical manifestation). The diagnostic value

2020 Clinical Infectious Diseases

17. Case fatality risk of the first pandemic wave of novel coronavirus disease 2019 (COVID-19) in China. Full Text available with Trip Pro

Case fatality risk of the first pandemic wave of novel coronavirus disease 2019 (COVID-19) in China. To assess the case fatality risk (CFR) of COVID-19 in mainland China, stratified by region and clinical category, and estimate key time-to-event intervals.We collected individual information and aggregated data on COVID-19 cases from publicly available official sources from December 29, 2019 to April 17, 2020. We accounted for right-censoring to estimate the CFR and explored the risk factors (...) that of mild-to-severe patients. Older age (OR 1.14 per year; 95%CI: 1.11-1.16), and being male (OR 1.83; 95%CI: 1.10-3.04) were risk factors for mortality. The time from symptom onset to first healthcare consultation, time from symptom onset to laboratory confirmation, and time from symptom onset to hospitalization were consistently longer for deceased patients than for those who recovered.Our CFR estimates based on laboratory-confirmed cases ascertained in mainland China suggest that COVID-19 is more

2020 Clinical Infectious Diseases

18. Novel Coronavirus Disease 2019 (COVID-19) Pneumonia Progression Course in 17 Discharged Patients: Comparison of Clinical and Thin-Section Computed Tomography Features During Recovery. Full Text available with Trip Pro

Novel Coronavirus Disease 2019 (COVID-19) Pneumonia Progression Course in 17 Discharged Patients: Comparison of Clinical and Thin-Section Computed Tomography Features During Recovery. Our objective was to retrospectively analyze the evolution of clinical features and thin-section computed tomography (CT) imaging of novel coronavirus disease 2019 (COVID-19) pneumonia in 17 discharged patients.Serial thin-section CT scans of 17 discharged patients with COVID-19 were obtained during recovery

2020 Clinical Infectious Diseases

19. COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection. Full Text available with Trip Pro

COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection. Recent retrospective studies from Wuhan, China suggest Novel Coronavirus Disease 2019 (COVID-19) may be associated with a hypercoagulable state and increased risk for venous thromboembolism. The overlap in the signs and symptoms of COVID-19 associated Acute Respiratory Distress Syndrome (ARDS) and COVID-19 with concurrent pulmonary embolism creates a diagnostic challenge (...) for emergency medicine physicians in patients already at risk for renal impairment. However, identifying features atypical for COVID-19 alone may play a role in the judicious use of Computed Tomography Angiography among these patients. Hemoptysis is seen in roughly 13% of pulmonary embolism cases and infrequently reported among COVID-19 infections. Additionally, the presence of right heart strain on electrocardiography (EKG) is a well described clinical presentations of pulmonary embolism not reported

2020 American Journal of Emergency Medicine

20. Prospective study comparing deep-throat saliva with other respiratory tract specimens in the diagnosis of novel coronavirus disease (COVID-19). Full Text available with Trip Pro

Prospective study comparing deep-throat saliva with other respiratory tract specimens in the diagnosis of novel coronavirus disease (COVID-19). Self-collected specimens has been advocated to avoid infectious exposure to healthcare workers. Self-induced sputum in those with a productive cough, and saliva in those without a productive cough have been proposed, but sensitivity remains uncertain.We performed a prospective study in two regional hospitals in Hong Kong.We prospectively examined 563

2020 Journal of Infectious Diseases

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>